$18.06
-1.02-5.35%
最終更新: Oct 2, 4:50 AM
$18.33
-0.75-3.93%
Benzinga
Benzinga
Benzinga
金曜日, 10 02
Benzinga
© 2026 Benzinga | All Rights Reserved
Vor Biopharma (VOR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.70 | $-0.78 | $-1.14 | $-3.68 |
| Actual | $-0.80 | $-0.73 | $-1.63 | $-3.33 |
| Surprise | -14.3% | +6.41% | -43.0% | +9.54% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.74 | $-0.78 | $-0.81 | $-0.30 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.80 | $-0.70 | -14.3 % |
| Q1 | May 13, 2026 | $-0.73 | $-0.78 | 6.41 % |
| Q4 | Mar 30, 2026 | $-1.63 | $-1.14 | -43.0 % |
| Q3 | Nov 13, 2025 | $-3.33 | $-3.68 | 9.54 % |